Comparison of 5-HT4 and 5-HT7 receptor expression and function in the circular muscle of the human colon.

[1]  K. Dev,et al.  Serotonin 5-HT7 receptors coupled to induction of interleukin-6 in human microglial MC-3 cells , 2005, Neuropharmacology.

[2]  S A Bustin,et al.  Quantitative real-time RT-PCR--a perspective. , 2005, Journal of molecular endocrinology.

[3]  J. Schuurkes,et al.  5‐HT4 receptors located on cholinergic nerves in human colon circular muscle , 2005, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[4]  R. Langer,et al.  Serotonin excites neurons in the human submucous plexus via 5-HT3 receptors. , 2005, Gastroenterology.

[5]  H. Irving,et al.  Influences of Gender and Region on Responses to 5-HT in the Rat Small Intestine , 2004, Pharmacology.

[6]  M. Gershon.  Review article: serotonin receptors and transporters — roles in normal and abnormal gastrointestinal motility , 2004, Alimentary pharmacology & therapeutics.

[7]  K. Krobert,et al.  Cloning, pharmacological characterisation and tissue distribution of a novel 5-HT4 receptor splice variant, 5-HT4(i) , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

[8]  Xiuli Zuo,et al.  Visceral perception thresholds after rectal thermal and pressure stimuli in irritable bowel syndrome patients , 2004, Journal of gastroenterology and hepatology.

[9]  J. Kapeller,et al.  Cloning, physical mapping and expression analysis of the human 5-HT3 serotonin receptor-like genes HTR3C, HTR3D and HTR3E. , 2003, Gene.

[10]  A. Moorman,et al.  Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data , 2003, Neuroscience Letters.

[11]  D. Middlemiss,et al.  [3 H]-SB-269970 radiolabels 5-HT7 receptors in rodent, pig and primate brain tissues , 2002, Neuropharmacology.

[12]  F. Pace,et al.  Tegaserod, a 5‐HT4 receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation , 2001, Alimentary pharmacology & therapeutics.

[13]  M. Crowell,et al.  The role of serotonin in the pathophysiology of irritable bowel syndrome. , 2001, The American journal of managed care.

[14]  D. Middlemiss,et al.  Quantitative mRNA analysis of five C-terminal splice variants of the human 5-HT4 receptor in the central nervous system by TaqMan real time RT-PCR. , 2001, Brain research. Molecular brain research.

[15]  K. Krobert,et al.  The cloned human 5-HT7 receptor splice variants: a comparative characterization of their pharmacology, function and distribution , 2001, Naunyn-Schmiedeberg's Archives of Pharmacology.

[16]  M. Pfaffl,et al.  A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.

[17]  Trond Brattelid,et al.  5-HT4(a) and 5-HT4(b) receptors have nearly identical pharmacology and are both expressed in human atrium and ventricle , 2001, Naunyn-Schmiedeberg's Archives of Pharmacology.

[18]  J. Schuurkes,et al.  5‐HT4 receptors on cholinergic nerves involved in contractility of canine and human large intestine longitudinal muscle , 2000, British Journal of Pharmacology.

[19]  S. Bustin.  Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. , 2000, Journal of molecular endocrinology.

[20]  M. Tonini,et al.  The interaction of antidepressant drugs with enteric 5-HT7 receptors , 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.

[21]  J. Hagan,et al.  Characterization of SB‐269970‐A, a selective 5‐HT7 receptor antagonist , 2000, British journal of pharmacology.

[22]  J. Hagan,et al.  [3H]‐SB‐269970 – A selective antagonist radioligand for 5‐HT7 receptors , 2000 .

[23]  P J Lovell,et al.  A novel, potent, and selective 5-HT(7) antagonist: (R)-3-(2-(2-(4-methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl) phen ol (SB-269970). , 2000, Journal of medicinal chemistry.

[24]  J. Leysen,et al.  5-HT7 receptors: current knowledge and future prospects. , 2000, Trends in pharmacological sciences.

[25]  M. Jurzak,et al.  Structure of the Human Serotonin 5‐HT4 Receptor Gene and Cloning of a Novel 5‐HT4 Splice Variant , 2000, Journal of neurochemistry.

[26]  J. Schuurkes,et al.  Evidence for 5‐HT7 receptors mediating relaxation of human colonic circular smooth muscle , 1999, British journal of pharmacology.

[27]  D. Drossman,et al.  Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5‐HT3 receptor antagonist , 1999, Alimentary pharmacology & therapeutics.

[28]  T. Branchek,et al.  Functional characterization of the recombinant human 5-hydroxytryptamine7(a) receptor isoform coupled to adenylate cyclase stimulation. , 1998, The Journal of pharmacology and experimental therapeutics.

[29]  R. Fischmeister,et al.  Cloning, Expression, and Pharmacology of Four Human 5‐Hydroxytryptamine4 Receptor Isoforms Produced by Alternative Splicing in the Carboxyl Terminus , 1998, Journal of neurochemistry.

[30]  R. Borman,et al.  Human colonic mucosa possesses a mixed population of 5-HT receptors. , 1996, European journal of pharmacology.

[31]  P. Mclean,et al.  Further investigation into the signal transduction mechanism of the 5‐HT4‐like receptor in the circular smooth muscle of human colon , 1996, British journal of pharmacology.

[32]  S. Mochizuki,et al.  Molecular cloning of human 5-hydroxytryptamine3 receptor: heterogeneity in distribution and function among species. , 1995, Molecular pharmacology.

[33]  R. Eglen,et al.  Characterization of a postjunctional 5-HT receptor mediating relaxation of guinea-pig isolated ileum. , 1995, European journal of pharmacology.

[34]  C. Grossman,et al.  Differences in response to 5‐HT4 receptor agonists and antagonists of the 5‐HT4‐like receptor in human colon circular smooth muscle , 1995, British journal of pharmacology.

[35]  P. Molenaar,et al.  A comparative study of functional 5‐HT4 receptors in human colon, rat oesophagus and rat ileum , 1995, British journal of pharmacology.

[36]  K. Bunce,et al.  Characterization of the 5‐hydroxytryptamine receptor type involved in inhibition of spontaneous activity of human isolated colonic circular muscle , 1994, British journal of pharmacology.

[37]  P P Humphrey,et al.  International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). , 1994, Pharmacological reviews.

[38]  J. Gale,et al.  GR113808: a novel, selective antagonist with high affinity at the 5‐HT4 receptor , 1994, British journal of pharmacology.

[39]  M. Jurzak,et al.  Differences in Signal Transduction of Two 5-HT4Receptor Splice Variants: Compound Specificity and Dual Coupling with Gαs- and Gαi/o-Proteins , 2002 .